The Association for the Advancement of Medical Instrumentation (AAMI) is reporting that with a new set of Medical Device User Fee Amendments (MDUFA IV) making their way through Congress, the Food and Drug Administration (FDA) is getting a jump-start on a plan to recognize accredited testing laboratories. Under this scheme, the agency would use reports from these laboratories during premarket reviews as evidence of conformity to recognized standards by manufacturers. The agency is asking for feedback on its proposal, which it outlined in a Federal Register notice published May 16. Under the current system, medical device manufacturers can include a “Declaration of Conformity” to identify which voluntary consensus standards they used in their application to meet premarket requirements for their devices. According to the FDA, this system “has not been consistently applied by sponsors in submissions,” causing “challenges for manufacturers and FDA alike.”
To read further from AAMI, CLICK HERE.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Infection Prevention in Low-Resource Settings: Two Infection Preventionists Consult in East Africa
January 29th 2024Infection preventionists Heather Saunders and Stephanie Mayoryk's journey to East Africa emphasizes the positive impact of infection prevention efforts in low-income countries. Despite challenges, their experience encourages IPs to engage globally, fostering hope and passion for providing excellent patient care.